1
|
Khurana A, Dalland JC, Young JR, Inwards DJ, Paludo J. Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis. Am J Hematol 2021; 96:E298-E301. [PMID: 33984157 DOI: 10.1002/ajh.26233] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2021] [Revised: 05/06/2021] [Accepted: 05/10/2021] [Indexed: 11/06/2022]
Affiliation(s)
- Arushi Khurana
- Division of Hematology Mayo Clinic Rochester Minnesota USA
| | - Joanna C. Dalland
- Department of Laboratory Medicine and Pathology, Division of Hematopathology Mayo Clinic Rochester Minnesota USA
| | - Jason R. Young
- Department of Radiology, Division of Nuclear Medicine Mayo Clinic Rochester Minnesota USA
| | | | - Jonas Paludo
- Division of Hematology Mayo Clinic Rochester Minnesota USA
| |
Collapse
|